REDHILL BIOPHARMA LTD. (RDHL) Operating cash flow 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.4MFY2024 · since FY2015: -$17.8M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.4M | +73.8% |
| FY2023 | -$35.8M | -22.7% |
| FY2022 | -$29.2M | +55.1% |
| FY2021 | -$65.0M | -33.9% |
| FY2020 | -$48.6M | -19.2% |
| FY2019 | -$40.7M | -18.2% |
| FY2018 | -$34.5M | +23.0% |
| FY2017 | -$44.8M | -58.4% |
| FY2016 | -$28.3M | -58.5% |
| FY2015 | -$17.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →